Renal handling of calcium and sodium in metastatic and non-metastatic malignancy.
- 1 March 1986
- Vol. 292 (6520), 583-586
- https://doi.org/10.1136/bmj.292.6520.583
Abstract
Investigation of the renal handling of calcium and sodium in rehydrated patients with hypercalcaemia associated with malignancy showed enhanced reabsorption of calcium in most cases. This was a feature of both metastatic and non-metastatic malignancy, and in this respect the patients were indistinguishable from patients with primary hyperparathyroidism. As the increased calcium reabsorption was inversely correlated with the rate of excretion of sodium modest salt loading can be used to inhibit this process. This is an important practical aspect of the treatment of patients with this type of hypercalcaemia.Keywords
This publication has 23 references indexed in Scilit:
- The Hypercalcemia of CancerNew England Journal of Medicine, 1984
- Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.BMJ, 1984
- Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells.Journal of Clinical Investigation, 1983
- COMPARISON OF INTRAVENOUS (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE AND VOLUME REPLETION IN TUMOUR-INDUCED HYPERCALCAEMIAThe Lancet, 1983
- The hypercalcemia of malignancy: Pathogenesis and managementMetabolism, 1982
- Biochemical Evaluation of Patients with Cancer-Associated HypercalcemiaNew England Journal of Medicine, 1980
- Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.Journal of Clinical Investigation, 1980
- Equilibrium and disequilibrium hypercalcemia new light on an old conceptMetabolic Bone Disease and Related Research, 1979
- INHIBITION OF OSTEOLYTIC BONE LESIONS BY (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- RELATION BETWEEN SERUM AND URINARY CALCIUM WITH PARTICULAR REFERENCE TO PARATHYROID ACTIVITYThe Lancet, 1969